294 related articles for article (PubMed ID: 14729970)
61. Protein kinase A-dependent transactivation by the E2A-Pbx1 fusion protein.
Ogo A; Waterman MR; Kamps MP; Kagawa N
J Biol Chem; 1995 Oct; 270(43):25340-3. PubMed ID: 7592695
[TBL] [Abstract][Full Text] [Related]
62. Functional cloning and characterization of a novel nonhomeodomain protein that inhibits the binding of PBX1-HOX complexes to DNA.
Abramovich C; Shen WF; Pineault N; Imren S; Montpetit B; Largman C; Humphries RK
J Biol Chem; 2000 Aug; 275(34):26172-7. PubMed ID: 10825160
[TBL] [Abstract][Full Text] [Related]
63. GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche.
Shiozawa Y; Pedersen EA; Taichman RS
Exp Hematol; 2010 Feb; 38(2):132-40. PubMed ID: 19922767
[TBL] [Abstract][Full Text] [Related]
64. Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis.
Lin CH; Wang Z; Duque-Afonso J; Wong SH; Demeter J; Loktev AV; Somervaille TCP; Jackson PK; Cleary ML
Sci Rep; 2019 Mar; 9(1):4915. PubMed ID: 30894657
[TBL] [Abstract][Full Text] [Related]
65. Role for homodimerization in growth deregulation by E2a fusion proteins.
Bayly R; LeBrun DP
Mol Cell Biol; 2000 Aug; 20(16):5789-96. PubMed ID: 10913162
[TBL] [Abstract][Full Text] [Related]
66. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
67. Heterogeneity of t(1;19)(q23;p13) acute leukaemias. French Haematological Cytology Group.
Troussard X; Rimokh R; Valensi F; Leboeuf D; Fenneteau O; Guitard AM; Manel AM; Schillinger F; Leglise C; Brizard A
Br J Haematol; 1995 Mar; 89(3):516-26. PubMed ID: 7734349
[TBL] [Abstract][Full Text] [Related]
68. The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Hong Y; Zhao X; Qin Y; Zhou S; Chang Y; Wang Y; Zhang X; Xu L; Huang X
Ann Hematol; 2018 Sep; 97(9):1547-1554. PubMed ID: 29705861
[TBL] [Abstract][Full Text] [Related]
69. Growth inhibition and apoptosis due to restoration of E2A activity in T cell acute lymphoblastic leukemia cells.
Park ST; Nolan GP; Sun XH
J Exp Med; 1999 Feb; 189(3):501-8. PubMed ID: 9927512
[TBL] [Abstract][Full Text] [Related]
70. The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF.
Inukai T; Inaba T; Ikushima S; Look AT
Mol Cell Biol; 1998 Oct; 18(10):6035-43. PubMed ID: 9742120
[TBL] [Abstract][Full Text] [Related]
71. Establishment of a novel cell line (TS-2) of pre-B acute lymphoblastic leukemia with a t(1;19) not involving the E2A gene.
Yoshinari M; Imaizumi M; Eguchi M; Ogasawara M; Saito T; Suzuki H; Koizumi Y; Cui Y; Sato A; Saisho T; Ichinohasama R; Matsubara Y; Kamada N; Iinuma K
Cancer Genet Cytogenet; 1998 Mar; 101(2):95-102. PubMed ID: 9494609
[TBL] [Abstract][Full Text] [Related]
72. High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia.
Bijl J; Sauvageau M; Thompson A; Sauvageau G
Genes Dev; 2005 Jan; 19(2):224-33. PubMed ID: 15655112
[TBL] [Abstract][Full Text] [Related]
73. E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells.
Bayly R; Chuen L; Currie RA; Hyndman BD; Casselman R; Blobel GA; LeBrun DP
J Biol Chem; 2004 Dec; 279(53):55362-71. PubMed ID: 15507449
[TBL] [Abstract][Full Text] [Related]
74. [Correlation of E2a-pbx1 expression level with clinical characteristics and early response to treatment in children with acute lymphoblastic leukemia].
Gao C; Li ZG; Zhao W; Wu MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):569-73. PubMed ID: 18549631
[TBL] [Abstract][Full Text] [Related]
75. Targeting TNF/IL-17/MAPK pathway in h
Luo H; Li Q; Hong J; Huang Z; Deng W; Wei K; Lu S; Wang H; Zhang W; Liu W
Haematologica; 2024 Feb; ():. PubMed ID: 38385270
[TBL] [Abstract][Full Text] [Related]
76. Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice.
Smith KS; Rhee JW; Naumovski L; Cleary ML
Mol Cell Biol; 1999 Jun; 19(6):4443-51. PubMed ID: 10330184
[TBL] [Abstract][Full Text] [Related]
77. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.
Higuchi M; O'Brien D; Kumaravelu P; Lenny N; Yeoh EJ; Downing JR
Cancer Cell; 2002 Feb; 1(1):63-74. PubMed ID: 12086889
[TBL] [Abstract][Full Text] [Related]
78. Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia.
Izraeli S; Henn T; Strobl H; Ludwig WD; Kovar H; Haas OA; Harbott J; Bartram CR; Gadner H; Lion T
Leukemia; 1993 Dec; 7(12):2054-6. PubMed ID: 8255105
[TBL] [Abstract][Full Text] [Related]
79. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.
Cuenco GM; Ren R
Oncogene; 2001 Dec; 20(57):8236-48. PubMed ID: 11781838
[TBL] [Abstract][Full Text] [Related]
80. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.
Altura RA; Inukai T; Ashmun RA; Zambetti GP; Roussel MF; Look AT
Blood; 1998 Aug; 92(4):1397-405. PubMed ID: 9694729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]